DK1291429T3 - Glutamin-fruktose-6-fosfat-amidotransferase-splice-variant og dets ekspressionsprodukt - Google Patents

Glutamin-fruktose-6-fosfat-amidotransferase-splice-variant og dets ekspressionsprodukt

Info

Publication number
DK1291429T3
DK1291429T3 DK01938602T DK01938602T DK1291429T3 DK 1291429 T3 DK1291429 T3 DK 1291429T3 DK 01938602 T DK01938602 T DK 01938602T DK 01938602 T DK01938602 T DK 01938602T DK 1291429 T3 DK1291429 T3 DK 1291429T3
Authority
DK
Denmark
Prior art keywords
gene
expression product
amino acid
protein
fructose
Prior art date
Application number
DK01938602T
Other languages
Danish (da)
English (en)
Inventor
Yasuchika Yamamoto
Takashi Okamoto
Tsutomu Fujiwara
Masashi Niimi
Hiroyuki Kyushiki
Atsunori Ueyama
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK1291429T3 publication Critical patent/DK1291429T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1096Transferases (2.) transferring nitrogenous groups (2.6)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK01938602T 2000-06-13 2001-06-12 Glutamin-fruktose-6-fosfat-amidotransferase-splice-variant og dets ekspressionsprodukt DK1291429T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000176631 2000-06-13
JP2000290679A JP4601143B2 (ja) 2000-06-13 2000-09-25 新規酵素遺伝子およびその発現産物
PCT/JP2001/004941 WO2001096574A1 (en) 2000-06-13 2001-06-12 Novel enzyme gene and its expression product

Publications (1)

Publication Number Publication Date
DK1291429T3 true DK1291429T3 (da) 2009-01-19

Family

ID=26593812

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01938602T DK1291429T3 (da) 2000-06-13 2001-06-12 Glutamin-fruktose-6-fosfat-amidotransferase-splice-variant og dets ekspressionsprodukt

Country Status (15)

Country Link
US (1) US7091018B2 (enExample)
EP (1) EP1291429B1 (enExample)
JP (1) JP4601143B2 (enExample)
KR (1) KR100882407B1 (enExample)
CN (1) CN100390286C (enExample)
AR (1) AR029130A1 (enExample)
AT (1) ATE407212T1 (enExample)
AU (2) AU2001264245B2 (enExample)
CA (1) CA2412880C (enExample)
DE (1) DE60135650D1 (enExample)
DK (1) DK1291429T3 (enExample)
ES (1) ES2312442T3 (enExample)
PT (1) PT1291429E (enExample)
TW (1) TWI232883B (enExample)
WO (1) WO2001096574A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE506614T1 (de) * 2005-06-20 2011-05-15 Exelixis Inc Gfats als modifikatoren des axin-wegs und verwendungsverfahren
US8106256B2 (en) * 2005-10-05 2012-01-31 Bayer Cropscience Ag Methods and means for producing hyaluronan
KR101430773B1 (ko) * 2006-06-30 2014-08-18 홋카이도 시스테무 사이엔스 가부시키가이샤 핵산 도입용 조성물
CN103301447B (zh) * 2013-06-25 2014-12-31 哈尔滨医科大学 DNA-PKcs在制备改变肿瘤细胞对MTX耐药性的药物中的应用
CN112980914A (zh) * 2019-12-12 2021-06-18 中国科学院大连化学物理研究所 Gfpt1基因作为靶点在筛选抗肿瘤药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021330A1 (en) * 1992-04-22 1993-10-28 Zymogenetics, Inc. Human glutamine:fructose-6-phosphate amino-transferase
JPH1018683A (ja) * 1996-06-29 1998-01-20 Tesco Joho Center:Kk 吊下扉のレール装置
US5876713A (en) * 1996-08-13 1999-03-02 Takeda Chemical Industries Ltd Glutamine: fructose-6-phosphate amidotransferase, its production and use
JP4175680B2 (ja) * 1996-08-13 2008-11-05 武田薬品工業株式会社 新規タンパク質およびそのdna
AU2216300A (en) * 1998-12-22 2000-07-12 G.D. Searle & Co. Glutamine: fructose-6-phosphate aminotransferase ii enzyme and their encoding nucleic acids

Also Published As

Publication number Publication date
ES2312442T3 (es) 2009-03-01
EP1291429A4 (en) 2004-05-26
JP4601143B2 (ja) 2010-12-22
EP1291429A1 (en) 2003-03-12
US20040132020A1 (en) 2004-07-08
CA2412880A1 (en) 2002-12-13
DE60135650D1 (de) 2008-10-16
TWI232883B (en) 2005-05-21
ATE407212T1 (de) 2008-09-15
PT1291429E (pt) 2008-12-15
AU6424501A (en) 2001-12-24
EP1291429B1 (en) 2008-09-03
CA2412880C (en) 2010-05-04
AU2001264245B2 (en) 2006-04-27
KR100882407B1 (ko) 2009-02-05
US7091018B2 (en) 2006-08-15
WO2001096574A1 (en) 2001-12-20
JP2002065284A (ja) 2002-03-05
CN1436239A (zh) 2003-08-13
KR20030011868A (ko) 2003-02-11
AR029130A1 (es) 2003-06-04
CN100390286C (zh) 2008-05-28

Similar Documents

Publication Publication Date Title
Haney et al. Peptide design for antimicrobial and immunomodulatory applications
RU2468080C2 (ru) Новый класс терапевтических белковых молекул
KR960700340A (ko) 안정한 살균/투과성-증가 단백질 생성물 및 그를 포함하는 제약학적 조성물(stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same)
DE69531889D1 (de) Biologisch aktive Fragmente des Glucagon ähnlichen, insulinotropen Peptides
WO2004078777A3 (en) Dipeptidyl-peptidase protected proteins
ATE64619T1 (de) Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
DE3587407D1 (de) Toxin-segment des kristallgens vom bacillus thuringiensis.
WO2001092497A3 (en) Human pancreatic islet glucose-6-phosphatase
DK1291429T3 (da) Glutamin-fruktose-6-fosfat-amidotransferase-splice-variant og dets ekspressionsprodukt
EP1279744A3 (en) Identification and use of molecules implicated in pain
DE60127113D1 (de) Gd3 mimetische peptide
DE60336353D1 (de) Rekombinantes protein mit krebsunterdrückender wirkung, sein codierendes gen und seine verwendung
ATE490324T1 (de) Nukleinsäuren kodierend für polypeptide mit chips aktivität
DE69925116D1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
RU2003129163A (ru) Полинуклеотид, который можно использовать для модулирования пролиферации раковых клеток
WO2003018829A3 (en) 6299, a human zinc carboxypeptidase family member and uses therefor
EP0887410A3 (en) DNA encoding a plasminogen activating protein
WO2002088378A3 (en) 66784, a novel human potassium channel and uses therefor
WO2006063800A8 (en) Cloning of honey bee allergen
DE602004023340D1 (de) Onkogen, davon abgeleitetes rekombinantes Protein und dessen Verwendung
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
EP1679372A4 (en) NEW PLEXIN POLYPEPTIDE, THIS CODING DNA AND USE THEREOF
EP1568775A4 (en) CANCER ASSOCIATED GEN
NZ505350A (en) DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours
JP2002335976A5 (enExample)